Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study

Cardiovascular disease (CVD) emerges as a major cause of death in patients with myelodysplastic syndrome (MDS), but predictors of fatal CVD and the effect of MDS‐specific treatments on CVD mortality remain largely unknown. In an analysis involving 831 patients with MDS with known causes of death, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Liapis, Konstantinos, Vrachiolias, Georgios, Papadopoulos, Vasileios, Kourakli, Alexandra, Galanopoulos, Athanasios G., Papoutselis, Menelaos, Papageorgiou, Sotirios G., Diamantopoulos, Panagiotis T., Pappa, Vassiliki, Viniou, Nora‐Athina, Vassilakopoulos, Theodoros P., Hatzimichael, Eleftheria, Bouronikou, Eleni, Ximeri, Maria, Pontikoglou, Charalambos, Panayiotidis, Panayiotis, Karakatsanis, Stamatis, Vardi, Anna, Symeonidis, Argiris, Kotsianidis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176014/
https://www.ncbi.nlm.nih.gov/pubmed/35847690
http://dx.doi.org/10.1002/jha2.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176014/
https://www.ncbi.nlm.nih.gov/pubmed/35847690
http://dx.doi.org/10.1002/jha2.30

Ejemplares similares